BeStock  
Markets › Compare › TRVI vs AUPH

TRVI vs AUPH

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
TRVI · Trevi Therapeutics$13.35 ▼ 2.70%
AUPH · Aurinia Pharmaceuticals$14.70 ▼ 1.28%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

82105129152176Nov 24, '25May 26, '26Nov 20, '26
  • TRVI +17.0%
  • AUPH -8.8%

Head to head

MetricTRVIAUPH
Price$13.35$14.70
Change today▼ 2.70%▼ 1.28%
Market cap$1.90B$1.97B
Return, 3 months-26.2%-11.3%
Return, year to date+6.6%-7.8%
Return, 1 year+21.5%-6.3%
P/E (TTM)–6.4
P/B6.33.0
P/E percentile vs own 5y14th67th
Dividend yield––
Revenue growth (YoY, latest qtr)–+13.9%
Net profit growth (YoY)-81.8%+0.5%
Gross margin–90.6%
Operating margin–48.6%
Net margin–97.7%
Return on equity-24.7%61.4%
Analyst target vs. price+107.6%+29.3%
Analyst buy share100%67%
RSI (14)4630
30-day volatility66.1%31.7%
Max drawdown, 1 year-39.1%-21.8%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • AUPH is the largest of the group by market value.
  • TRVI has returned the most over the past year.
  • AUPH has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top